Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Blomberg

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Computer-Aided Molecular Design|March 14, 2009
Design of compound libraries for fragment screeningNiklas Blomberg, David A Cosgrove, Peter W Kenny, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compoundsChristian Tyrchan, Niklas Blomberg, Ola Engkvist, et al.
Proteins|September 22, 2009
Comparative binding energy analysis for binding affinity and target selectivity predictionStefan Henrich, Isabella Feierberg, Ting Wang, et al.
F1000Research|July 28, 2017
General guidelines for biomedical software developmentLuis Bastiao Silva, Rafael C Jimenez, Niklas Blomberg, et al.
Journal of Computer-Aided Molecular Design|March 27, 2007
Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening dataClaire L Gavaghan, Catrin Hasselgren Arnby, Niklas Blomberg, et al.
Bioinformatics (Oxford, England)|June 27, 2021
ELIXIR: providing a sustainable infrastructure for life science data at European scaleJennifer Harrow, Rachel Drysdale, Andrew Smith, et al.
Nature Cancer|February 6, 2024
Roadmap for a European cancer data management and precision medicine infrastructureMacha Nikolski, Eivind Hovig, Fatima Al-Shahrour, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombinStephen Hanessian, Karolina Ersmark, Xiaotian Wang, et al.
Molecular Informatics|January 12, 2013
SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity DataMats Eriksson, Ingemar Nilsson, Thierry Kogej, et al.
Drug Discovery Today|November 7, 2012
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG caseThierry Kogej, Niklas Blomberg, Peter J Greasley, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Computer-Aided Molecular Design|March 14, 2009
Design of compound libraries for fragment screeningNiklas Blomberg, David A Cosgrove, Peter W Kenny, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compoundsChristian Tyrchan, Niklas Blomberg, Ola Engkvist, et al.
Proteins|September 22, 2009
Comparative binding energy analysis for binding affinity and target selectivity predictionStefan Henrich, Isabella Feierberg, Ting Wang, et al.
F1000Research|July 28, 2017
General guidelines for biomedical software developmentLuis Bastiao Silva, Rafael C Jimenez, Niklas Blomberg, et al.
Journal of Computer-Aided Molecular Design|March 27, 2007
Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening dataClaire L Gavaghan, Catrin Hasselgren Arnby, Niklas Blomberg, et al.
Bioinformatics (Oxford, England)|June 27, 2021
ELIXIR: providing a sustainable infrastructure for life science data at European scaleJennifer Harrow, Rachel Drysdale, Andrew Smith, et al.
Nature Cancer|February 6, 2024
Roadmap for a European cancer data management and precision medicine infrastructureMacha Nikolski, Eivind Hovig, Fatima Al-Shahrour, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombinStephen Hanessian, Karolina Ersmark, Xiaotian Wang, et al.
Molecular Informatics|January 12, 2013
SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity DataMats Eriksson, Ingemar Nilsson, Thierry Kogej, et al.
Drug Discovery Today|November 7, 2012
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG caseThierry Kogej, Niklas Blomberg, Peter J Greasley, et al.
Pageof 5